Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
Cancer
|
December 18, 2008
Sex and race in bladder cancer: what we have learned and future directions
Mark H Katz, Gary D Steinberg
The Journal of Urology
|
September 18, 2009
Editorial comment
Mark H Katz, Gary D Steinberg
The Journal of Urology
|
August 18, 2009
Editorial comment
Mark H Katz, Gary D Steinberg
World Journal of Urology
|
April 14, 2009
The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates
Mark H Katz, Scott E Eggener
Urologic Oncology
|
November 23, 2005
Treatment of nonretroperitoneal residual germ cell tumor masses
Mark H Katz, James M McKiernan
Nature Clinical Practice. Urology
|
July 24, 2008
Should fluorescence cystoscopy be used for transurethral resection in patients with high-grade T1 bladder cancer?
Mark H Katz, Gary D Steinberg
Reviews in Urology
|
June 8, 2007
High-risk, clinically localized prostate cancer: is monotherapy adequate?
Mark H Katz, James M McKiernan
The Urologic Clinics of North America
|
May 9, 2007
Management of non-retroperitoneal residual germ cell tumor masses
Mark H Katz, James M McKiernan
Urology
|
April 13, 2010
Radical cystectomy in patients previously treated for localized prostate cancer
Gautam Jayram, Mark H Katz, Gary D Steinberg
Journal of Endourology
|
April 25, 2007
Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B
Mark H Katz, Michael W Lee, Mantu Gupta
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
Cancer
|
December 18, 2008
Sex and race in bladder cancer: what we have learned and future directions
Mark H Katz, Gary D Steinberg
The Journal of Urology
|
September 18, 2009
Editorial comment
Mark H Katz, Gary D Steinberg
The Journal of Urology
|
August 18, 2009
Editorial comment
Mark H Katz, Gary D Steinberg
World Journal of Urology
|
April 14, 2009
The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates
Mark H Katz, Scott E Eggener
Urologic Oncology
|
November 23, 2005
Treatment of nonretroperitoneal residual germ cell tumor masses
Mark H Katz, James M McKiernan
Nature Clinical Practice. Urology
|
July 24, 2008
Should fluorescence cystoscopy be used for transurethral resection in patients with high-grade T1 bladder cancer?
Mark H Katz, Gary D Steinberg
Reviews in Urology
|
June 8, 2007
High-risk, clinically localized prostate cancer: is monotherapy adequate?
Mark H Katz, James M McKiernan
The Urologic Clinics of North America
|
May 9, 2007
Management of non-retroperitoneal residual germ cell tumor masses
Mark H Katz, James M McKiernan
Urology
|
April 13, 2010
Radical cystectomy in patients previously treated for localized prostate cancer
Gautam Jayram, Mark H Katz, Gary D Steinberg
Journal of Endourology
|
April 25, 2007
Setting a new standard for topical therapy of upper-tract transitional-cell carcinoma: BCG and interferon-alpha2B
Mark H Katz, Michael W Lee, Mantu Gupta
Page
of 5